Shandong Weigao Group Medical Polymer Co (SHWGF) AI Stock Analysis

14 Followers

Shandong Weigao Group Medical Polymer Co

(Other OTC:SHWGF)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Recurring consumables demandThe company serves routine clinical workflows with single-use products that require repeated replenishment. This recurring volume-based model can support durable demand as hospital utilization and patient volumes generate ongoing purchases across infusion, blood-related and other medical consumable categories.

Negative Factors

Sharp revenue contractionThe steep 2025 revenue decline signals a material weakening in demand, sales execution or procurement conditions relative to the prior base. If sustained, lower revenue would reduce operating scale and make it harder to absorb fixed costs, support investment and restore historical growth.

Shandong Weigao Group Medical Polymer Co (SHWGF) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $1.92B
Dividend Yield: 4.85%
Average Volume (3M): 5,567
Price to Earnings (P/E): 9.4
Beta (1Y): 0.33
Revenue Growth: 7.17%
EPS Growth: -27.09%
Country: US
Employees: 13,310
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Instruments & Supplies

Shandong Weigao Group Medical Polymer Co Business Overview & Revenue Model

Company Description

Shandong Weigao Group Medical Polymer Company Limited, founded in 2000 and situated in Weihai, People's Republic of China, specializes in the research, development, production, and distribution of disposable medical devices across mainland China. The...

Shandong Weigao Group Medical Polymer Co Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

SHWGF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HK:3600	80Outperform	HKD 6.81B	9.86	20.11%	4.02%	12.50%	44.44%
HK:6929	78Outperform	HKD 3.07B	8.80	10.50%	5.40%	16.25%	7.80%
HK:6699	66Neutral	HKD 14.09B	41.51	8.95%	1.16%	―	―
HK:1358	61Neutral	HKD 1.28B	26.77	1.10%	3.44%	-1.64%	-68.67%
HK:1501	59Neutral	HKD 6.21B	21.63	9.64%	0.87%	34.94%	12.99%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

* Healthcare Sector Average

Performance Comparison

SHWGF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
SHWGF	Shandong Weigao Group Medical Polymer Co Class H	0.43	-0.24	-35.96%
HK:1358	PW Medtech Group Ltd.	0.90	-0.46	-33.68%
HK:3600	Modern Dental Group Limited	7.20	2.14	42.24%
HK:1501	Shanghai Kindly Medical Instruments Co., Ltd. Class H	30.00	0.08	0.26%
HK:6699	Angelalign Technology Inc.	81.00	19.97	32.73%
HK:6929	OrbusNeich Medical Group Holdings Limited	3.70	-0.37	-8.98%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Shandong Weigao Group Medical Polymer Co AI Stock Analysis